Neoplasms Metastasis Recruiting Phase 2 Trials for Everolimus (DB01590)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01960829Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety StudyTreatment